HMS alumni Keith Dunleavy, founder and CEO of health care technology company Inovalon, and his wife, Katherine Dunleavy, a ...

The results, published Nov. 7 in Current Biology, reveal that some of the stories told for decades about the individuals’ ...

Breast cancer rates rose by 1 percent per year from 2012-2021 for all U.S. women combined, with steeper increases for women ...

David Walt, the Hansjörg Wyss Professor of Bioinspired Engineering at HMS and professor of pathology at Brigham and Women’s Hospital, is operating at a microscopic level, observing cell abnormalities ...

CHASERR is unlike traditional genes, which are used as blueprints for making messenger RNA and proteins that perform various functions in cells. Instead, CHASERR codes for a long noncoding RNA, or ...

Gary Ruvkun, professor of genetics at Harvard Medical School and an investigator at Massachusetts General Hospital, received the 2024 Nobel Prize in Physiology or Medicine for his co-discovery of ...

Vivian Kobusingye Birchall, SM, is the host of ActonTV’s Health Care Blind Spots Series, where she interviews stakeholders, physicians, researchers, and industry policymakers on the status of cancer ...

Ryan Flynn, assistant professor of stem cell and regenerative biology in the Blavatnik Institute at Harvard Medical School, has received a National Institutes of Health (NIH) Director’s Transformative ...

Vivian Kobusingye Birchall, SM, has dedicated her education and media career to communication, global health, and blind spots in health care. Birchall is a recent alumni of the Master of Science in ...